Verastem Inc (VSTM)
10.19
-0.65
(-6.00%)
USD |
NASDAQ |
Apr 18, 16:00
10.26
+0.07
(+0.69%)
After-Hours: 20:00
Verastem Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2022 | 0.3355 |
| December 31, 2021 | 0.0028 |
| September 30, 2021 | 0.0025 |
| June 30, 2021 | 0.2304 |
| March 31, 2021 | 0.1917 |
| December 31, 2020 | 0.1653 |
| September 30, 2020 | 0.4357 |
| June 30, 2020 | 0.4885 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.449 |
| December 31, 2019 | 14.44 |
| September 30, 2019 | 6.327 |
| June 30, 2019 | 2.714 |
| March 31, 2019 | 1.379 |
| December 31, 2018 | 0.9691 |
| September 30, 2018 | 0.2329 |
| June 30, 2018 | 0.1963 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0025
Minimum
Sep 2021
14.44
Maximum
Dec 2019
2.149
Average
0.3856
Median
Debt to Equity Ratio Benchmarks
| Amgen Inc | 10.37 |
| Johnson & Johnson | 0.4265 |
| Ampio Pharmaceuticals Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 149.72M |
| Total Liabilities (Quarterly) | 92.34M |
| Shareholders Equity (Quarterly) | 57.37M |